142 related articles for article (PubMed ID: 25934174)
1. Clusterin transcript variants expression in thyroid tumor: a potential marker of malignancy?
Fuzio P; Napoli A; Ciampolillo A; Lattarulo S; Pezzolla A; Nuzziello N; Liuni S; Giorgino F; Maiorano E; Perlino E
BMC Cancer; 2015 May; 15():349. PubMed ID: 25934174
[TBL] [Abstract][Full Text] [Related]
2. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.
Rossi ED; Martini M; Bizzarro T; Capodimonti S; Cenci T; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM
Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of estrogen receptor-α in human papillary thyroid carcinomas studied by laser- capture microdissection and molecular biology.
Di Vito M; De Santis E; Perrone GA; Mari E; Giordano MC; De Antoni E; Coppola L; Fadda G; Tafani M; Carpi A; Russo MA
Cancer Sci; 2011 Oct; 102(10):1921-7. PubMed ID: 21707866
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor receptor-2 expression in thyroid tumor progression: potential diagnostic application.
Redler A; Di Rocco G; Giannotti D; Frezzotti F; Bernieri MG; Ceccarelli S; D'Amici S; Vescarelli E; Mitterhofer AP; Angeloni A; Marchese C
PLoS One; 2013; 8(8):e72224. PubMed ID: 23977259
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the expression of CLU isoforms in endometrial proliferative diseases.
Fuzio P; Valletti A; Napoli A; Napoli G; Cormio G; Selvaggi L; Liuni S; Pesole G; Maiorano E; Perlino E
Int J Oncol; 2013 Jun; 42(6):1929-44. PubMed ID: 23589125
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical Subcellular Localization of Protein Biomarkers Distinguishes Benign from Malignant Thyroid Nodules: Potential for Fine-Needle Aspiration Biopsy Clinical Application.
Ralhan R; Veyhl J; Chaker S; Assi J; Alyass A; Jeganathan A; Somasundaram RT; MacMillan C; Freeman J; Vescan AD; Witterick IJ; Walfish PG
Thyroid; 2015 Nov; 25(11):1224-34. PubMed ID: 26131603
[TBL] [Abstract][Full Text] [Related]
7. Comparative Evaluation of β-Catenin and E-Cadherin Expression in Liquid Aspiration Biopsy Specimens of Thyroid Nodules.
Isaeva AV; Zima AP; Saprina TV; Kasoyan KT; Popov OS; Brynova OV; Berezkina IS; Vasil'eva OA; Ryazantseva NV; Shabalova IP; Litvinova LS; Pak YD; Novitskii VV
Bull Exp Biol Med; 2016 Jun; 161(2):288-91. PubMed ID: 27383156
[TBL] [Abstract][Full Text] [Related]
8. Genetics of clusterin isoform expression and Alzheimer's disease risk.
Ling IF; Bhongsatiern J; Simpson JF; Fardo DW; Estus S
PLoS One; 2012; 7(4):e33923. PubMed ID: 22506010
[TBL] [Abstract][Full Text] [Related]
9. High clusterin (CLU) mRNA expression levels in tumors of colorectal cancer patients predict a poor prognostic outcome.
Artemaki PI; Sklirou AD; Kontos CK; Liosi AA; Gianniou DD; Papadopoulos IN; Trougakos IP; Scorilas A
Clin Biochem; 2020 Jan; 75():62-69. PubMed ID: 31672651
[TBL] [Abstract][Full Text] [Related]
10. Clusterin gene is predominantly regulated by histone modifications in human colon cancer and ectopic expression of the nuclear isoform induces cell death.
Deb M; Sengupta D; Rath SK; Kar S; Parbin S; Shilpi A; Pradhan N; Bhutia SK; Roy S; Patra SK
Biochim Biophys Acta; 2015 Aug; 1852(8):1630-45. PubMed ID: 25917404
[TBL] [Abstract][Full Text] [Related]
11. Identification of new biomarkers for human papillary thyroid carcinoma employing NanoString analysis.
Chitikova Z; Pusztaszeri M; Makhlouf AM; Berczy M; Delucinge-Vivier C; Triponez F; Meyer P; Philippe J; Dibner C
Oncotarget; 2015 May; 6(13):10978-93. PubMed ID: 25868389
[TBL] [Abstract][Full Text] [Related]
12. Expression of ECM1 and MMP-2 in follicular thyroid lesions among Egyptians.
Abdel Salam R; El-Badry N; Rizk A; El-Sedfy A; Kamel N; El-Abd E
Cancer Biomark; 2015; 15(4):441-58. PubMed ID: 25812648
[TBL] [Abstract][Full Text] [Related]
13. Tumor suppressor role of the CL2/DRO1/CCDC80 gene in thyroid carcinogenesis.
Ferraro A; Schepis F; Leone V; Federico A; Borbone E; Pallante P; Berlingieri MT; Chiappetta G; Monaco M; Palmieri D; Chiariotti L; Santoro M; Fusco A
J Clin Endocrinol Metab; 2013 Jul; 98(7):2834-43. PubMed ID: 23666966
[TBL] [Abstract][Full Text] [Related]
14. PRDX1 and PRDX6 are repressed in papillary thyroid carcinomas via BRAF V600E-dependent and -independent mechanisms.
Nicolussi A; D'Inzeo S; Mincione G; Buffone A; Di Marcantonio MC; Cotellese R; Cichella A; Capalbo C; Di Gioia C; Nardi F; Giannini G; Coppa A
Int J Oncol; 2014 Feb; 44(2):548-56. PubMed ID: 24316730
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of S100C in thyroid lesions.
Torres-Cabala C; Panizo-Santos A; Krutzsch HC; Barazi H; Namba M; Sakaguchi M; Roberts DD; Merino MJ
Int J Surg Pathol; 2004 Apr; 12(2):107-15. PubMed ID: 15173915
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D receptor expression is linked to potential markers of human thyroid papillary carcinoma.
Izkhakov E; Somjen D; Sharon O; Knoll E; Aizic A; Fliss DM; Limor R; Stern N
J Steroid Biochem Mol Biol; 2016 May; 159():26-30. PubMed ID: 26907966
[TBL] [Abstract][Full Text] [Related]
17. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells.
Degl'Innocenti D; Romeo P; Tarantino E; Sensi M; Cassinelli G; Catalano V; Lanzi C; Perrone F; Pilotti S; Seregni E; Pierotti MA; Greco A; Borrello MG
Endocr Relat Cancer; 2013 Feb; 20(1):23-37. PubMed ID: 23132790
[TBL] [Abstract][Full Text] [Related]
18. Clusterin plays an important role in clear renal cell cancer metastasis.
Wang X; Luo L; Dong D; Yu Q; Zhao K
Urol Int; 2014; 92(1):95-103. PubMed ID: 24008723
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical and in situ hybridization analyses of midkine expression in thyroid papillary carcinoma.
Kato M; Maeta H; Kato S; Shinozawa T; Terada T
Mod Pathol; 2000 Oct; 13(10):1060-5. PubMed ID: 11048798
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development.
Zhang X; Li D; Li M; Ye M; Ding L; Cai H; Fu D; Lv Z
Int J Cancer; 2014 Jan; 134(2):257-67. PubMed ID: 23457043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
